Cargando…
Toward Therapeutic Targeting of Bone Marrow Leukemic Niche Protective Signals in B-Cell Acute Lymphoblastic Leukemia
B-cell acute lymphoblastic leukemia (B-ALL) represents the malignant counterpart of bone marrow (BM) differentiating B cells and occurs most frequently in children. While new combinations of chemotherapeutic agents have dramatically improved the prognosis for young patients, disease outcome remains...
Autores principales: | Delahaye, Marjorie C., Salem, Kaoutar-Insaf, Pelletier, Jeoffrey, Aurrand-Lions, Michel, Mancini, Stéphane J. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820772/ https://www.ncbi.nlm.nih.gov/pubmed/33489914 http://dx.doi.org/10.3389/fonc.2020.606540 |
Ejemplares similares
-
Murine Bone Marrow Niches from Hematopoietic Stem Cells to B Cells
por: Aurrand-Lions, Michel, et al.
Publicado: (2018) -
In quest for leukemia initiating cells in AML
por: De Grandis, Maria, et al.
Publicado: (2018) -
Adhesion Molecules Involved in Stem Cell Niche Retention During Normal Haematopoiesis and in Acute Myeloid Leukaemia
por: Grenier, Julien M. P., et al.
Publicado: (2021) -
Targeting Leukemia-Initiating Cells and Leukemic Niches: The Next Therapy Station for T-Cell Acute Lymphoblastic Leukemia?
por: Zhang, Ziting, et al.
Publicado: (2022) -
Pitavastatin Is Anti-Leukemic in a Bone Marrow Microenvironment Model of B-Lineage Acute Lymphoblastic Leukemia
por: Piktel, Debbie, et al.
Publicado: (2022)